vs

Side-by-side financial comparison of United Homes Group, Inc. (UHG) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

Zai Lab Ltd is the larger business by last-quarter revenue ($127.1M vs $123.4M, roughly 1.0× United Homes Group, Inc.). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs -8.5%). United Homes Group, Inc. produced more free cash flow last quarter ($616.0K vs $-26.7M). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 10.6%).

Invitation Homes Inc. is a public company traded on the New York Stock Exchange. It is headquartered in the Lincoln Center building in Dallas, Texas. Dallas B. Tanner is chief executive officer. As of 2017, the company was reportedly the largest owner of single-family rental homes in the United States. As of July 2024, the company owned about 84,000 rental homes in 16 markets. Seventeen percent of their rental income is from California.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

UHG vs ZLAB — Head-to-Head

Bigger by revenue
ZLAB
ZLAB
1.0× larger
ZLAB
$127.1M
$123.4M
UHG
Growing faster (revenue YoY)
ZLAB
ZLAB
+25.6% gap
ZLAB
17.1%
-8.5%
UHG
More free cash flow
UHG
UHG
$27.3M more FCF
UHG
$616.0K
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
10.6%
UHG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
UHG
UHG
ZLAB
ZLAB
Revenue
$123.4M
$127.1M
Net Profit
$3.2M
Gross Margin
17.5%
51.0%
Operating Margin
1.3%
-54.6%
Net Margin
2.6%
Revenue YoY
-8.5%
17.1%
Net Profit YoY
380.4%
EPS (diluted)
$0.05
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
UHG
UHG
ZLAB
ZLAB
Q4 25
$123.4M
$127.1M
Q3 25
$90.8M
$115.4M
Q2 25
$105.5M
$109.1M
Q1 25
$87.0M
$105.7M
Q4 24
$134.8M
$108.5M
Q3 24
$118.6M
$101.8M
Q2 24
$109.4M
$100.1M
Q1 24
$100.8M
$87.1M
Net Profit
UHG
UHG
ZLAB
ZLAB
Q4 25
$3.2M
Q3 25
$-31.3M
$-36.0M
Q2 25
$-6.3M
$-40.7M
Q1 25
$18.2M
$-48.4M
Q4 24
$667.0K
Q3 24
$-7.3M
$-41.7M
Q2 24
$28.6M
$-80.3M
Q1 24
$24.9M
$-53.5M
Gross Margin
UHG
UHG
ZLAB
ZLAB
Q4 25
17.5%
51.0%
Q3 25
17.7%
59.5%
Q2 25
18.9%
60.6%
Q1 25
16.2%
63.6%
Q4 24
16.2%
61.5%
Q3 24
18.9%
64.1%
Q2 24
17.9%
64.9%
Q1 24
16.0%
61.4%
Operating Margin
UHG
UHG
ZLAB
ZLAB
Q4 25
1.3%
-54.6%
Q3 25
-1.7%
-42.3%
Q2 25
1.8%
-50.3%
Q1 25
-2.3%
-53.3%
Q4 24
1.8%
-62.6%
Q3 24
3.1%
-66.6%
Q2 24
-0.0%
-76.0%
Q1 24
-1.0%
-80.7%
Net Margin
UHG
UHG
ZLAB
ZLAB
Q4 25
2.6%
Q3 25
-34.5%
-31.2%
Q2 25
-6.0%
-37.3%
Q1 25
20.9%
-45.8%
Q4 24
0.5%
Q3 24
-6.2%
-40.9%
Q2 24
26.2%
-80.2%
Q1 24
24.7%
-61.4%
EPS (diluted)
UHG
UHG
ZLAB
ZLAB
Q4 25
$0.05
$-0.05
Q3 25
$-0.53
$-0.03
Q2 25
$-0.11
$-0.04
Q1 25
$0.31
$-0.04
Q4 24
$0.11
$-0.09
Q3 24
$-0.15
$-0.04
Q2 24
$0.50
$-0.08
Q1 24
$0.44
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
UHG
UHG
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$24.4M
$689.6M
Total DebtLower is stronger
$67.5M
Stockholders' EquityBook value
$57.4M
$715.5M
Total Assets
$276.6M
$1.2B
Debt / EquityLower = less leverage
1.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
UHG
UHG
ZLAB
ZLAB
Q4 25
$24.4M
$689.6M
Q3 25
$25.6M
$717.2M
Q2 25
$36.5M
$732.2M
Q1 25
$25.0M
$757.3M
Q4 24
$22.6M
$779.7M
Q3 24
$25.8M
$616.1M
Q2 24
$24.9M
$630.0M
Q1 24
$28.7M
$650.8M
Total Debt
UHG
UHG
ZLAB
ZLAB
Q4 25
$67.5M
Q3 25
$67.4M
Q2 25
$67.3M
Q1 25
$67.2M
Q4 24
$67.2M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
UHG
UHG
ZLAB
ZLAB
Q4 25
$57.4M
$715.5M
Q3 25
$52.9M
$759.9M
Q2 25
$82.2M
$791.7M
Q1 25
$87.1M
$810.8M
Q4 24
$66.9M
$840.9M
Q3 24
$19.8M
$667.7M
Q2 24
$25.7M
$704.2M
Q1 24
$-4.7M
$762.2M
Total Assets
UHG
UHG
ZLAB
ZLAB
Q4 25
$276.6M
$1.2B
Q3 25
$293.1M
$1.2B
Q2 25
$281.1M
$1.2B
Q1 25
$266.2M
$1.2B
Q4 24
$265.4M
$1.2B
Q3 24
$282.6M
$985.3M
Q2 24
$284.0M
$987.4M
Q1 24
$287.2M
$988.4M
Debt / Equity
UHG
UHG
ZLAB
ZLAB
Q4 25
1.18×
Q3 25
1.27×
Q2 25
0.82×
Q1 25
0.77×
Q4 24
1.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
UHG
UHG
ZLAB
ZLAB
Operating Cash FlowLast quarter
$1.4M
$-26.0M
Free Cash FlowOCF − Capex
$616.0K
$-26.7M
FCF MarginFCF / Revenue
0.5%
-21.0%
Capex IntensityCapex / Revenue
0.6%
0.5%
Cash ConversionOCF / Net Profit
0.44×
TTM Free Cash FlowTrailing 4 quarters
$-21.6M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
UHG
UHG
ZLAB
ZLAB
Q4 25
$1.4M
$-26.0M
Q3 25
$-23.8M
$-32.0M
Q2 25
$1.6M
$-31.0M
Q1 25
$1.2M
$-61.7M
Q4 24
$27.4M
$-55.8M
Q3 24
$7.2M
$-26.8M
Q2 24
$-1.2M
$-42.2M
Q1 24
$-17.9M
$-90.1M
Free Cash Flow
UHG
UHG
ZLAB
ZLAB
Q4 25
$616.0K
$-26.7M
Q3 25
$-24.8M
$-35.0M
Q2 25
$1.3M
$-33.9M
Q1 25
$1.2M
$-63.2M
Q4 24
$27.4M
$-58.4M
Q3 24
$7.2M
$-28.2M
Q2 24
$-42.9M
Q1 24
$-17.9M
$-91.1M
FCF Margin
UHG
UHG
ZLAB
ZLAB
Q4 25
0.5%
-21.0%
Q3 25
-27.3%
-30.4%
Q2 25
1.2%
-31.1%
Q1 25
1.4%
-59.9%
Q4 24
20.3%
-53.8%
Q3 24
6.1%
-27.7%
Q2 24
-42.9%
Q1 24
-17.8%
-104.5%
Capex Intensity
UHG
UHG
ZLAB
ZLAB
Q4 25
0.6%
0.5%
Q3 25
1.1%
2.6%
Q2 25
0.2%
2.6%
Q1 25
0.0%
1.5%
Q4 24
0.0%
2.4%
Q3 24
0.0%
1.3%
Q2 24
0.0%
0.7%
Q1 24
0.0%
1.1%
Cash Conversion
UHG
UHG
ZLAB
ZLAB
Q4 25
0.44×
Q3 25
Q2 25
Q1 25
0.07×
Q4 24
41.09×
Q3 24
Q2 24
-0.04×
Q1 24
-0.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

UHG
UHG

GSH South Carolina$116.3M94%
Rosewood$5.9M5%
Other Segment$1.1M1%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons